CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 9 (Patent Applications = 3)

Average Co-Inventor Count = 3.0

ph-index = 5

Forward Citations = 119(Granted Patents)

Location History:

Tochigi-ken, JP (1997)
Shimotsuga-gun, JP (2011 - 2014)
Tochigi, JP (1998 - 2016)

Company Filing History:

21 out of 185

Kyorin Pharmaceutical Co., Ltd.

patents

4 out of 124

Teijin Pharma Limited

patents

3 out of 191

Sagami Chemical Research Center

where one patent can have more than one assignee

Years Active: 1997-2016

Loading Chart...

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9452977 - Cyclopentylacrylamide derivative (2016-09-27),

2. 8946440 - Cyclopentylacrylamide derivative (2015-02-03),

3. 8901112 - Spirocyclic aminoquinolones as GSK-3 inhibitors (2014-12-02),

4. 8476261 - Spirocyclic aminoquinolones as GSK-3 inhibitors (2013-07-02),

5. 8222407 - Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position (2012-07-17),

6. 8173649 - Glucokinase activator (2012-05-08),

7. 8063221 - Aminoquinolones as GSK-3 inhibitors (2011-11-22),

8. 8053465 - Bicycloester derivative (2011-11-08),

9. 8034819 - Glucokinase activator (2011-10-11),

10. 7915427 - Process for producing aminoacetyl pyrrolidine carbonitrile derivative and intermediate for production thereof (2011-03-29),

11. 7754757 - Bicycloester derivative (2010-07-13),

12. 7582659 - Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof (2009-09-01),

13. 7560569 - Bicycloamide derivative (2009-07-14),

14. 7514571 - Bicyclo derivative (2009-04-07),

15. 7462633 - Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof (2008-12-09),

Title: Yasumichi Fukuda: Innovator in Diabetes Treatment

Introduction

Yasumichi Fukuda, an esteemed inventor based in Tochigi, Japan, has made significant contributions to the field of pharmaceutical innovations. With a remarkable portfolio consisting of 21 patents, Fukuda is known for his dedication to advancing medical treatments, particularly concerning diabetes and obesity.

Latest Patents

One of Fukuda's latest innovations is the Cyclopentylacrylamide derivative, a compound that possesses hypoglycemic effects. This compound, along with its pharmaceutically acceptable salts, is designed for the treatment or prevention of diabetes, obesity, and related conditions. The compound features a general formula where the variable R can represent a variety of chemical groups, including hydrogen, halogens, amino and hydroxyl groups, among others. This innovative approach showcases Fukuda's commitment to creating impactful health solutions.

Career Highlights

Throughout his career, Yasumichi Fukuda has been associated with notable organizations such as Kyorin Pharmaceutical Co., Ltd. and Teijin Pharma Limited. His work within these companies has been instrumental in developing breakthrough medications aimed at treating chronic health issues.

Collaborations

Fukuda has collaborated with prominent colleagues in the field, such as Yoshikazu Asahina and Shiro Terashima. These partnerships have facilitated the sharing of ideas and expertise, furthering advancements in pharmaceutical research and innovation.

Conclusion

Yasumichi Fukuda stands out as a notable inventor in the realm of pharmaceuticals, especially his work concerning diabetes treatment. His extensive patent portfolio and collaborations with leading companies and professionals exemplify his dedication to innovation in medical science.

This text is generated by artificial intelligence and may not be accurate.